Café-biodisponibilidad-salud cardiovascular

1. Esquivel P, Jiménez VM. Functional properties of coffee and coffee by-products. Food Research International 2012;46:488-495. 2. Valenzuela A. El café y sus efectos en la salud cardiovascular y en la salud materna. Rev Chil Nutr 2010;37:514-523. 3. Bonita JS, Mandarano M, Shuta D, Vinson J. Coffee and cardiovascular disease: In vitro, cellular, animal, and human studies. Pharmacological Research 2007;55:187-198. 4. Ranheim T, Halvorsen B. Coffee consumption and human health – beneficial or detrimental? – Mechanisms for effects of coffee consumption on different risk factors for cardiovascular disease and type 2 diabetes mellitus. Molecular Nutrition & Food Research 2005;49:274-284. 5. Mursu J, Voutilainen S, Nurmi T, et al. The effects of coffee consumption on lipid peroxidation and plasma total homocysteine concentrations: a clinical trial. Free Radical Biology and Medicine 2005;38:527-534. 6. Del Castillo MD, Gordon MH, Ames JM. Peroxyl radical-scavenging activity of coffee brews. European Food Research and Technology 2005;221:471-477. 7. Ferruzzi MG. The influence of beverage composition on delivery of phenolic compounds from coffee and tea. Physiology & Behavior 2010;100:33-41. 8. Manach C, Scalbert A, Morand C, Remesy C, Jimenez L. Polyphenols: food sources and bioavailability. Am J Clin Nutr 2004;79:727-747. 9. Del Castillo MD, Ames JM, Gordon MH. Effect of roasting on the antioxidant activity of coffee brews. J Agric Food Chem 2002;50:3698-703. 10. Clifford MN. Chlorogenic acids and other cinnamates - nature, occurrence and dietary burden. Journal of the Science of Food and Agriculture 1999;79:362-372. 11. Hollman PCH, Cassidy A, Comte B, et al. The Biological Relevance of Direct Antioxidant Effects of Polyphenols for Cardiovascular Health in Humans Is Not Established. The Journal of Nutrition 2011;141:989S-1009S. 12. Cao G, Prior RL. Comparison of different analytical methods for assessing total antioxidant capacity of human serum. Clin Chem 1998;44:1309-1315. 13. Parras P, Martínez-Tomé M, Jiménez AM, Murcia MA. Antioxidant capacity of coffees of several origins brewed following three different procedures. Food Chemistry 2007;102:582-592. 14. Benzie IFF, Strain JJ. The Ferric Reducing Ability of Plasma (FRAP) as a Measure of "Antioxidant Power": The FRAP Assay. Analytical Biochemistry 1996;239:70-76. 15. Festy D. ANTIOXIDANTES: Guía práctica ¿Qué son? ¿Qué funciones realizan? ¿Qué beneficios aportan? 1ª ed. Barcelona: Robinbook, 2007. 16. Parke DV. Nutritional antioxidants and disease prevention: mechanisms of action. In: Basu TK, Temple NJ, Garg ML, eds. Antioxidants in human health and disease. Wallingford CABI Publishing, 1999:1-13. 17. Thomas JA. Estrés oxidativo y defensa oxidante. Nutrición en salud y enfermedad. 9ª ed. México D.F.: Mc Graw Hill, 2002:863-873. 18. Marin G, G. P. Contenido de ácidos clorogénicos en granos de Coffea arabica L. y C. canephora, según el desarrollo del fruto Cenicafé 2008;59:07-28. 19. Bravo L. Polyphenols: Chemistry, Dietary Sources, Metabolism, and Nutritional Significance. Nutrition Reviews 1998;56:317-333. 20. Leighton F, Urquiaga I, Urzúa U. Antioxidantes naturales. Impacto en la salud. 8° Congreso Latinoamericano de Grasas y Aceites. Santiago de Chile, 1999. 21. Richelle M, Tavazzi I, Offord E. Comparison of the antioxidant activity of commonly consumed polyphenolic beverages (coffee, cocoa, and tea) prepared per cup serving. J Agric Food Chem 2001;49:3438-42. 22. Scalbert A, Williamson G. Dietary intake and bioavailability of polyphenols. J Nutr 2000;130:2073S-85S. 23. Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J 2007;28:2375-414. 24. Ford ES, Ajani UA, Croft JB, et al. Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 2007;356:2388-98. 25. WHO. Preventing chronic disease: a vital investment. 2005:33. 26. Gidding SS, Lichtenstein AH, Faith MS, et al. Implementing American Heart Association pediatric and adult nutrition guidelines: a scientific statement from the American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Cardiovascular Disease in the Young, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, and Council for High Blood Pressure Research. Circulation 2009;119:1161-75. 27. OMS. Dieta, nutrición y prevencion de enfermedades crónicas. Informe de una consulta mixta de expertos OMS/FAO. Ginebra, 2003. 28. WHO. Cardiovascular disease. Fact sheet Nº 317. Geneva, 2009. 29. Franzini L, Ardigo D, Valtuena S, et al. Food selection based on high total antioxidant capacity improves endothelial function in a low cardiovascular risk population. Nutr Metab Cardiovasc Dis 2010. 30. Di Castelnuovo A, di Giuseppe R, Iacoviello L, de Gaetano G. Consumption of cocoa, tea and coffee and risk of cardiovascular disease. European Journal of Internal Medicine 2011. 31. Tavani A, Bertuzzi M, Gallus S, Negri E, La Vecchia C. Risk factors for non-fatal acute myocardial infarction in Italian women. Prev Med 2004;39:128-34. 32. Zampelas A, Panagiotakos DB, Pitsavos C, Chrysohoou C, Stefanadis C. Associations between coffee consumption and inflammatory markers in healthy persons: the ATTICA study. Am J Clin Nutr 2004;80:862-867. 33. Papamichael CM, Aznaouridis KA, Karatzis EN, et al. Effect of coffee on endothelial function in healthy subjects: the role of caffeine. Clin Sci (Lond) 2005;109:55-60. 34. Buscemi S, Verga S, Batsis JA, et al. Acute effects of coffee on endothelial function in healthy subjects. Eur J Clin Nutr 2010;64:483-489. 35. Hamer M. Coffee and health: Explaining conflicting results in hypertension. J Hum Hypertens 2006;20:909-12. 36. Lopez-Garcia E, van Dam RM, Qi L, Hu FB. Coffee consumption and markers of inflammation and endothelial dysfunction in healthy and diabetic women. Am J Clin Nutr 2006;84:888-893. 37. Lopez-Garcia E, Rodriguez-Artalejo F, Li TY, Mukamal KJ, Hu FB, van Dam RM. Coffee consumption and mortality in women with cardiovasculardisease. The American Journal of Clinical Nutrition 2011;94:218-224. 38. Wu J-n, Ho SC, Zhou C, et al. Coffee consumption and risk of coronary heart diseases: A meta-analysis of 21 prospective cohort studies. International Journal of Cardiology 2009;137:216-225. 39. Higdon JV, Frei B. Coffee and Health: A Review of Recent Human Research. Critical Reviews in Food Science and Nutrition 2006;46:101-123. 40. Vinson JA. Caffeine and incident hypertension in women. JAMA 2006;295:2135; author reply 2137. 41. Kempf K, Herder C, Erlund I, et al. Effects of coffee consumption on subclinical inflammation and other risk factors for type 2 diabetes: a clinical trial. The American Journal of Clinical Nutrition 2010;91:950-957. 42. Shechter M, Shalmon G, Scheinowitz M, et al. Impact of Acute Caffeine Ingestion on Endothelial Function in Subjects With and Without Coronary Artery Disease. The American Journal of Cardiology 2011;107:1255-1261. 43. Floegel A, Pischon T, Bergmann MM, Teucher B, Kaaks R, Boeing H. Coffee consumption and risk of chronic disease in the European Prospective Investigation into Cancer and Nutrition (EPIC)–Germany study. The American Journal of Clinical Nutrition 2012. 44. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891-904. 45. Lopez-Garcia E. Coffee consumption and risk of chronic diseases: changing our views. The American Journal of Clinical Nutrition 2012;95:787-788. 46. Natella F, Nardini M, Giannetti I, Dattilo C, Scaccini C. Coffee Drinking Influences Plasma Antioxidant Capacity in Humans. Journal of Agricultural and Food Chemistry 2002;50:6211-6216. 47. Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C. Chlorogenic acid compounds from coffee are differentially absorbed and metabolized in humans. J Nutr 2007;137:2196-201. 48. Echeverri D, Montes FR, Cabrera M, Galan A, Prieto A. Caffeine's Vascular Mechanisms of Action. Int J Vasc Med 2010;2010:834060. 49. WHO. Preventing chronic disease: a vital investment. Geneva; 2005.p. 33. 50. Mozaffarian D, Wilson PW, Kannel WB. Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease. Circulation 2008;117:3031-8. 51. Sies H. Polyphenols and health: Update and perspectives. Archives of Biochemistry and Biophysics 2010;501:2-5. 52. Dauchet L, Amouyel P, Hercberg S, Dallongeville J. Fruit and vegetable consumption and risk of coronary heart disease: a meta-analysis of cohort studies. J Nutr 2006;136:2588-93. 53. Lichtenstein AH, Appel LJ, Brands M, et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation 2006;114:82-96. 54. Weichselbaum E, Buttriss JL. Polyphenols in the diet. Nutrition Bulletin 2010;35:157-164. 55. Del Rio D, Costa LG, Lean MEJ, Crozier A. Polyphenols and health: What compounds are involved? Nutrition, metabolism, and cardiovascular diseases : NMCD 2010;20:1-6. 56. Herrera E, Jiménez R, Aruoma OI, Hercberg S, Sánchez-García I, Fraga C. Aspects of antioxidant foods and supplements in health and disease. Nutrition Reviews 2009;67:S140-S144. 57. Butt MS, Sultan MT. Coffee and its consumption: benefits and risks. Crit Rev Food Sci Nutr 2011;51:363-73. 58. Cho ES, Jang YJ, Hwang MK, Kang NJ, Lee KW, Lee HJ. Attenuation of oxidative neuronal cell death by coffee phenolic phytochemicals. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 2009;661:18-24. 59. Majer BJ, Hofer E, Cavin C, et al. Coffee diterpenes prevent the genotoxic effects of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) and N-nitrosodimethylamine in a human derived liver cell line (HepG2). Food and Chemical Toxicology 2005;43:433-441. 60. Muriel P, Arauz J. Coffee and liver diseases. Fitoterapia;In Press, Corrected Proof. 61. Paur I, Balstad TR, Blomhoff R. Degree of roasting is the main determinant of the effects of coffee on NF-[kappa]B and EpRE. Free Radical Biology and Medicine 2010;48:1218-1227. 62. Suzuki A, Yamamoto N, Jokura H, et al. Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats. Journal of Hypertension 2006;24:1075-1082 10.1097/01.hjh.0000226196.67052.c0. 63. Spiller MA. The chemical components of coffee. Gene A. Spiller, ed. Caffein. CRC Press 1998, p. 103 - 167. 64. Renouf M, Guy PA, Marmet C, et al. Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: small intestine and colon are key sites for coffee metabolism. Mol Nutr Food Res 2010;54:760-6. 65. Farah A, Donangelo CM. Phenolic compounds in coffee. Brazilian Journal of Plant Physiology 2006;18:23-36. 66. Sato Y, Itagaki S, Kurokawa T, et al. In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid. International Journal of Pharmaceutics 2011;403:136-138. 67. Krings U, Berger RG. Antioxidant activity of some roasted foods. Food Chemistry 2001;72:223-229. 68. Natella F, Nardini M, Belelli F, Scaccini C. Coffee drinking induces incorporation of phenolic acids into LDL and increases the resistance of LDL to ex vivo oxidation in humans. The American Journal of Clinical Nutrition 2007;86:604-609. 69. Hoelzl C, Knasmüller S, Wagner K-H, et al. Instant coffee with high chlorogenic acid levels protects humans against oxidative damage of macromolecules. Molecular Nutrition & Food Research 2010;9999:NA. 70. Pellegrini N, Serafini M, Colombi B, et al. Total Antioxidant Capacity of Plant Foods, Beverages and Oils Consumed in Italy Assessed by Three Different In Vitro Assays. J. Nutr. 2003;133:2812-2819. 71. Nicoli MC, Anese M, Manzocco L, Lerici CR. Antioxidant Properties of Coffee Brews in Relation to the Roasting Degree. Lebensmittel-Wissenschaft und-Technologie 1997;30:292-297. 72. Sánchez-González I, Jiménez-Escrig A, Saura-Calixto F. In vitro antioxidant activity of coffees brewed using different procedures (Italian, espresso and filter). Food Chemistry 2005;90:133-139. 73. Andueza S, Cid C, Cristina Nicoli M. Comparison of antioxidant and pro-oxidant activity in coffee beverages prepared with conventional and "Torrefacto" coffee. Lebensmittel-Wissenschaft und-Technologie 2004;37:893-897. 74. Charurin P, Ames JM, del Castillo MD. Antioxidant activity of coffee model systems. J Agric Food Chem 2002;50:3751-6. 75. Stadler RH, Varga N, Hau J, Vera FA, Welti DH. Alkylpyridiniums. 1. Formation in model systems via thermal degradation of trigonelline. J Agric Food Chem 2002;50:1192-9. 76. Somoza V, Lindenmeier M, Wenzel E, Frank O, Erbersdobler HF, Hofmann T. Activity-Guided Identification of a Chemopreventive Compound in Coffee Beverage Using in Vitro and in Vivo Techniques. Journal of Agricultural and Food Chemistry 2003;51:6861-6869. 77. Devasagayam TPA, Kamat JP, Mohan H, Kesavan PC. Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen species. Biochimica et Biophysica Acta (BBA) - Biomembranes 1996;1282:63-70. 78. Duthie GG, Duthie SJ, Kyle JA. Plant polyphenols in cancer and heart disease: implications as nutritional antioxidants. Nutr Res Rev 2000;13:79-106. 79. Natella F, Scaccini C. Role of coffee in modulation of diabetes risk. Nutrition Reviews 2012;70:207-217. 80. Seals DR, Jablonski KL, Donato AJ. Aging and vascular endothelial function in humans. Clin Sci (Lond) 2011;120:357-75. 81. Levonen AL, Vahakangas E, Koponen JK, Yla-Herttuala S. Antioxidant gene therapy for cardiovascular disease: current status and future perspectives. Circulation 2008;117:2142-50. 82. Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52. 83. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation 2004;109:III15-9. 84. Carpentier YA, Komsa-Penkova RS. Clinical Nutrition University. The place of nutrition in the prevention of cardiovascular diseases (CVDs). e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism 2011;6:e272-e282. 85. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-421. 86. Badimon L, Storey RF, Vilahur G. Update on lipids, inflammation and atherothrombosis. Thrombosis and haemostasis 2011;105 Suppl 1:S34-42. 87. Lekakis J, Abraham P, Balbarini A, et al. Methods for evaluating endothelial function: a position statement from the European Society of Cardiology Working Group on Peripheral Circulation. European Journal of Cardiovascular Prevention & Rehabilitation 2011. 88. Widlansky ME, Gokce N, Keaney JF, Jr., Vita JA. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 2003;42:1149-60. 89. Buckley DI, Fu R, Freeman M, Rogers K, Helfand M. C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force. Ann Intern Med 2009;151:483-95. 90. Plumb GW, Garcia-Conesa MT, Kroon PA, Rhodes M, Ridley S, Williamson G. Metabolism of chlorogenic acid by human plasma, liver, intestine and gut microflora. Journal of the Science of Food and Agriculture 1999;79:390-392. 91. Renouf M, Guy P, Marmet C, et al. Plasma appearance and correlation between coffee and green tea metabolites in human subjects. British Journal of Nutrition 2010;104:1635-1640. 92. Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem 2002;50:5735-41. 93. Monteiro M, Farah A, Perrone D, Trugo LC, Donangelo C. Chlorogenic Acid Compounds from Coffee Are Differentially Absorbed and Metabolized in Humans. J. Nutr. 2007;137:2196-2201. 94. Renouf M, Guy PA, Marmet C, et al. Measurement of caffeic and ferulic acid equivalents in plasma after coffee consumption: Small intestine and colon are key sites for coffee metabolism. Mol Nutr Food Res 2010. 95. Williamson G, Dionisi F, Renouf M. Flavanols from green tea and phenolic acids from coffee: Critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages. Molecular Nutrition & Food Research 2011;55:864-873. 96. Pulido R, Hernandez-Garcia M, Saura-Calixto F. Contribution of beverages to the intake of lipophilic and hydrophilic antioxidants in the Spanish diet. Eur J Clin Nutr 2003;57:1275-82. 97. Brezová V, Slebodová A, Stasko A. Coffee as a source of antioxidants: An EPR study. Food Chemistry 2009;114:859-868. 98. Vignoli JA, Bassoli DG, Benassi MT. Antioxidant Activity, Polyphenols, Caffeine and Melanoidins in Soluble Coffee: The Influence of Processing Conditions and Raw Material. Food Chemistry 2010;In Press, Accepted Manuscript. 99. Ramalakshmi K, Rahath Kubra I, Jagan Mohan Rao L. Antioxidant potential of low-grade coffee beans. Food Research International 2008;41:96-103. 100. Ramalakshmi K, Rao LJM, Takano-Ishikawa Y, Goto M. Bioactivities of low-grade green coffee and spent coffee in different in vitro model systems. Food Chemistry 2009;115:79-85. 101. Sacchetti G, Di Mattia C, Pittia P, Mastrocola D. Effect of roasting degree, equivalent thermal effect and coffee type on the radical scavenging activity of coffee brews and their phenolic fraction. Journal of Food Engineering 2009;90:74-80. 102. Mnatsakanyan M, Goodie TA, Conlan XA, et al. High performance liquid chromatography with two simultaneous on-line antioxidant assays: Evaluation and comparison of espresso coffees. Talanta 2010;81:837-842. 103. Kuskoski EM, Asuero AG, Troncoso AM, Mancini-Filho J, Fett R. Aplicación de diversos métodos químicos para determinar actividad antioxidante en pulpa de frutos. Ciência e Tecnologia de Alimentos 2005;25:726-732. 104. Fernández-Pachón MS, Villano D, Troncoso AM, García-Parrilla MC. Revisión de los métodos de evaluación de la actividad antioxidante in vitro del vino y valoración de sus efectos in vivo. ALAN 2006;56:110-122. 105. Namba T, Matsuse T. A historical study of coffee in Japanese and Asian countries: focusing the medicinal uses in Asian traditional medicines. Yakushigaku Zasshi 2002;37:65-75. 106. Yukawa GS, Mune M, Otani H, et al. Effects of coffee consumption on oxidative susceptibility of low-density lipoproteins and serum lipid levels in humans. Biochemistry (Mosc) 2004;69:70-4. 107. Buscemi S, Verga S, Batsis JA, et al. Dose-dependent effects of decaffeinated coffee on endothelial function in healthy subjects. Eur J Clin Nutr 2009;63:1200-1205. 108. Umemura T, Ueda K, Nishioka K, et al. Effects of acute administration of caffeine on vascular function. Am J Cardiol 2006;98:1538-41. 109. Duffy SJ, Keaney JF, Jr., Holbrook M, et al. Short- and long-term black tea consumption reverses endothelial dysfunction in patients with coronary artery disease. Circulation 2001;104:151-6. 110. Hatano Y, Mizumoto K, Yoshiyama T, Yamamoto M, Iranami H. Endothelium-dependent and -independent vasodilation of isolated rat aorta induced by caffeine. Am J Physiol 1995;269:H1679-84. 111. Echeverri D, Montes FR, Delgadillo A, Beltran M, Buitrago L. In vitro effect of caffeine on internal mammary artery rings used in cardiac revascularization surgery. Biomedica 2008;28:298-304. 112. Montes FR, Cabrera M, Delgadillo A, Salgar C, Echeverri D. The role of potassium channels in the vasodilatory effect of caffeine in human internal mammary arteries. Vascular Pharmacology 2009;50:132-136. 113. Buscemi S, Batsis JA, Arcoleo G, Verga S. Coffee and endothelial function: a battle between caffeine and antioxidants. Eur J Clin Nutr 2010;64:1242-1243. 114. Gaziano TA. Cardiovascular disease in the developing world and its cost-effective management. Circulation 2005;112:3547-53. 115. Young IS, Woodside JV. Antioxidants in health and disease. J Clin Pathol 2001;54:176-86. 116. Kotseva K. Global preventive policies. Strategies at European and worldwide level. Rev Esp Cardiol 2008;61:960-70. 117. Riksen NP, Rongen GA, Smits P. Acute and long-term cardiovascular effects of coffee: Implications for coronary heart disease. Pharmacology & Therapeutics 2009;121:185-191. 118. Rechner AR, Kuhnle G, Bremner P, Hubbard GP, Moore KP, Rice-Evans CA. The metabolic fate of dietary polyphenols in humans. Free Radic Biol Med 2002;33:220-35. 119. Niki E. Assessment of antioxidant capacity in vitro and in vivo. Free Radic Biol Med 2010;49:503-15. 120. Medina S, Gil JI, Ferreres F, García-Viguera C, Gil-Izquierdo A. UPLC-TripleQuad-MS/MS method for 13 prostanoid analyzes in human urine and quantitative 24 h values in healthy volunteers in a controlled constant diet. Mass Spectrometry 2012;26:1249-1257. 121. Tietz NW, editor. Clinical Guide to Laboratory Tests, 3rd ed. Philadelphia, WB Saunders, 1995:130. 122. Di Napoli M, Papa F, Bocola V. C-reactive protein in ischemic stroke: an independent prognostic factor. Stroke 2001;32:917-24. 123. Corretti MC, Anderson TJ, Benjamin EJ, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002;39:257-65. 124. Barac A, Campia U, Panza JA. Methods for evaluating endothelial function in humans. Hypertension 2007;49:748-60. 125. Romitelli F, Santini SA, Chierici E, et al. Comparison of nitrite/nitrate concentration in human plasma and serum samples measured by the enzymatic batch Griess assay, ion-pairing HPLC and ion-trap GC-MS: the importance of a correct removal of proteins in the Griess assay. J Chromatogr B Analyt Technol Biomed Life Sci 2007;851:257-67. 126. Pickering TG, Hall JE, Appel LJ, et al. Recommendations for blood pressure measurement in humans and experimental animals: part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation 2005;111:697-716. 127. Routh JI, Shane NA, Arredondo EG, Paul WD. Determination of caffeine in serum and urine. Clin Chem 1969;15:661-8. 128. Lohman T, Roche A, R M. Anthropometric standardization reference manual: Champaign: Human Kinetics Books 1988.